Page last updated: 2024-12-08
carpropamid
Description
carpropamid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
carpropamid : A cyclopropylcarboxamide obtained by formal condensation of the carboxy group of 2,2-dichloro-1-ethyl-3-methylcyclopropanecarboxylic acid with the amino group of 1-(4-chlorophenyl)ethylamine. A rice fungicide with specific action against Pyricularia oryzae. It is not highly toxic to mammals but shows a moderate level of toxicity to birds, fish and earthworms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 153847 |
CHEBI ID | 3434 |
SCHEMBL ID | 22262 |
MeSH ID | M0293233 |
Synonyms (18)
Synonym |
2,2-dichloro-n-[1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide |
CHEBI:3434 |
104030-54-8 |
carpropamid |
2,2-dichloro-n-[1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropane-1-carboxamide |
cyclopropanecarboxamide, 2,2-dichloro-n-(1-(4-chlorophenyl)ethyl)-1-ethyl-3-methyl- |
(1rs,3sr)-2,2-dichloro-n-(r)-1-(4-chlorophenyl)ethyl-1-ethyl-3-methylcyclopropanecarboxamide |
carpropamid [iso] |
unii-zs46tan742 |
zs46tan742 , |
AKOS015888200 |
SCHEMBL22262 |
DTXSID4057922 |
RXDMAYSSBPYBFW-UHFFFAOYSA-N |
SR-01000883725-1 |
sr-01000883725 |
carpropamid, pestanal(r), analytical standard |
Q27106077 |
Roles (4)
Role | Description |
EC 4.2.1.94 (scytalone dehydratase) inhibitor | An EC 4.2.1.* (hydro-lyases) inhibitor that interferes with the action of scytalone dehydratase (EC 4.2.1.94). |
xenobiotic | A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. |
melanin synthesis inhibitor | A depigmentation agent which inhibits the synthesis of melanin. |
antifungal agrochemical | Any substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (3)
Class | Description |
cyclopropylcarboxamide | Carboxamides RC(=O)NR'R'' where R is a cyclopropyl group. |
monochlorobenzenes | Any member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine. |
amide fungicide | Compounds that contain an amide group as a key feature of their structure and which have been used as fungicides. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 27.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 27.74 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 5.04 (4.65) | Search Engine Demand Index | 26.67 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |